Microbiome of Donor Iron Deficient Study



Status:Enrolling by invitation
Conditions:Iron Deficiency Anemia, Anemia
Therapuetic Areas:Hematology
Healthy:No
Age Range:18 - 75
Updated:2/6/2019
Start Date:January 2017
End Date:December 2021

Use our guide to learn which trials are right for you!

Microbiome of Donor Iron Deficient Study (DIDS)

The goal of this pilot study is to test whether the microbiome is affected by intravenous
iron repletion.

The colonic microbiome, the community of bacteria living in our gut, is essential in human
health and disease. Iron is an essential nutrient for both bacteria and humans. In the United
States, of the donors who provided the ~15 million units of red blood cells that were
collected for transfusion, 69% were repeat donors. Although iron deficiency is surprisingly
prevalent in first-time donors, its prevalence is even higher in these particularly
altruistic frequent donors, (i.e., up to 49% and 66% of male and female repeat donors,
respectively), manifested as iron depletion or iron-deficient erythropoiesis. Iron deficiency
from blood donation is associated with fatigue, restless leg syndrome, decreased physical
endurance and work capacity, and impaired concentration, attention, and other neurocognitive
functions; however, these conclusions are not based on definitive studies and have not yet
changed blood donation policy. The goal is to conduct a prospective, double-blind, randomized
controlled trial, recruiting 60 healthy regular donors who meet donation standards, while
exhibiting iron-deficient erythropoiesis by laboratory test criteria. In this ancillary
study, we will determine what effect donor iron deficiency and IV iron repletion have on the
gut microbiome.

Inclusion Criteria:

- Current participant of the associated randomized controlled trial conducted at
Columbia University Medical Center (therefore invited to participate in this optional
ancillary study).

Exclusion Criteria:

- Not a current participant of the associated randomized controlled trial conducted at
Columbia University Medical Center.
We found this trial at
1
site
630 W 168th St
New York, New York
212-305-2862
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
?
mi
from
New York, NY
Click here to add this to my saved trials